Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 11/20 | 0.85 |
| ▸ | ADORA2A | P29274 | 8/20 | 0.56 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.56 |
| ▸ | PI4KA | P42356 | 2/20 | 0.51 |
| ▸ | PI4K2B | Q8TCG2 | 2/20 | 0.51 |
| ▸ | PI4K2A | Q9BTU6 | 2/20 | 0.51 |
| ▸ | PI4KB | Q9UBF8 | 2/20 | 0.51 |
| ▸ | GSK3B | P49841 | 1/20 | 0.49 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9040228 | 1.00 | AHCY (0.85) | AHCYADORA2AADORA1PI4KAPI4K2B | |
| SCHEMBL8186426 | 0.82 | AHCY (1.00) | AHCYADORA2AADORA1PI4KAPI4K2B | |
| SCHEMBL1020380 | 0.79 | AHCY (1.00) | AHCYADORA2AADORA1PI4KAPI4K2B | |
| SCHEMBL13667843 | 0.78 | AHCY (0.72) | AHCYADORA2AADORA1PI4KAPI4K2B | |
| SCHEMBL8185183 | 0.76 | AHCY (0.64) | AHCYADORA2AADORA1PI4KAPI4K2B | |
| SCHEMBL8185176 | 0.76 | AHCY (0.64) | AHCYADORA2AADORA1PI4KAPI4K2B | |
| SCHEMBL8185180 | 0.76 | AHCY (0.64) | AHCYADORA2AADORA1PI4KAPI4K2B | |
| SCHEMBL2384723 | 0.76 | AHCY (0.65) | AHCY | |
| SCHEMBL1871838 | 0.75 | ADORA2A (0.75) | AHCYADORA2AADORA1PI4KAPI4K2B | |
| SCHEMBL6158904 | 0.75 | AHCY (0.76) | AHCYADORA2AADORA1PI4KAPI4K2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0705264-A1 | CARBO-ACYCLIC NUCLEOSIDE DERIVATIVES AS ANTIVIRAL AND ANTINEOPLASTIC AGENTS | MERRELL PHARMACEUTICALS INC. (US) | 1996-04-10 | — | — | EP | disclosed |